New technical manager for Life Scientific Ltd.

Life Scientific Ltd. has appointed Ruth Stanley as its UK technical manager. This new role within the company reflects the growing portfolio of its unique off-patent crop protection products registered for use in the UK.

Previously Campaign Manager at BASF for cereal herbicides and PGR’s, Mrs Stanley brings a wealth of experience and first hand farming knowledge to the role, as she is an active partner in her family arable farming enterprise in Leicestershire. Mrs Stanley is also a BASIS examiner.

In her new role Mrs Stanley will be the point of contact for advisors and growers providing them with the technical support needed to fully utilise the Life Scientific product portfolio.

“I am very excited to be joining Life Scientific and believe its unique approach in bringing off-patent products to market faster than ever before, will play a crucial part in providing the solutions that UK farming businesses are looking for in order to maintain sustainability going forward.”

“Farm businesses are currently under pressure to maintain profitability in a very unsure and challenging environment, so keeping costs down without compromising yield and quality is of paramount importance,” says Mrs Stanley.

Established in 1995, Life Scientific is co-owned (50/50) by its founder and CEO, Nicola Mitchell, and by French co-op group, InVivo.  The company, currently employs 60 people and has an annual turnover of €50 million.

Recent developments have also seen the appointment of a German managing director, Stefan Knittel, marking the formal entry of Life Scientific to the German market in the autumn 2018 – a key milestone in the growth of the company.

Dr Bill Lankford, Life Scientific’s UK country manager points out that the reason the company has been able to bring so many products so quickly to the UK market place is the company’s ability to reverse engineer a product from the original, meaning that the resulting product is accepted as comparable by the regulatory authority.

All of Life Scientific products will have full generic registration – there are no parallel imports.

He points out that this speed of development is a considerable competitive advantage against a background of pressure on farmers to reduce their cost of production, and on generic companies to secure a return on their investment in product development in a “highly unpredictable regulatory environment”